FNDC5/irisin mitigates the cardiotoxic impacts of cancer chemotherapeutics by modulating ROS-dependent and -independent mechanisms
Cardiotoxicity remains a major limiting factor in the clinical implementation of anthracycline chemotherapy. Though the etiology of doxorubicin-dependent heart damage has yet to be fully elucidated, the ability of doxorubicin to damage DNA and trigger oxidative stress have been heavily implicated in...
| Published in: | Redox Biology |
|---|---|
| Main Authors: | Manish Kumar, Abhishek Singh Sengar, Anushree Lye, Pranesh Kumar, Sukhes Mukherjee, Dinesh Kumar, Priyadip Das, Suvro Chatterjee, Adele Stewart, Biswanath Maity |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231725000400 |
Similar Items
Corrigendum to “FNDC5/irisin mitigates the cardiotoxic impacts of cancer chemotherapeutics by modulating ROS-dependent and -independent mechanisms” [Redox Biol. 80 (2025) 103527]
by: Manish Kumar, et al.
Published: (2025-09-01)
by: Manish Kumar, et al.
Published: (2025-09-01)
RGS6 drives cardiomyocyte death following nucleolar stress by suppressing Nucleolin/miRNA-21
by: Abhishek Singh Sengar, et al.
Published: (2024-02-01)
by: Abhishek Singh Sengar, et al.
Published: (2024-02-01)
FNDC5/Irisin: Physiology and Pathophysiology
by: Rashid Waseem, et al.
Published: (2022-02-01)
by: Rashid Waseem, et al.
Published: (2022-02-01)
The Role of FNDC5/Irisin in Cardiovascular Disease
by: Maciej Grzeszczuk, et al.
Published: (2024-02-01)
by: Maciej Grzeszczuk, et al.
Published: (2024-02-01)
RGS11-CaMKII complex mediated redox control attenuates chemotherapy-induced cardiac fibrosis
by: Kiran Das, et al.
Published: (2022-11-01)
by: Kiran Das, et al.
Published: (2022-11-01)
The role of exercise-related FNDC5/irisin in depression
by: Yaqi Liu, et al.
Published: (2024-10-01)
by: Yaqi Liu, et al.
Published: (2024-10-01)
FNDC5/Irisin in dementia and cognitive impairment: update and novel perspective
by: Xiaofeng Guo, et al.
Published: (2024-07-01)
by: Xiaofeng Guo, et al.
Published: (2024-07-01)
Cardiotoxicity in chemotherapeutic agents
by: Vitorino Modesto dos Santos, et al.
Published: (2021-03-01)
by: Vitorino Modesto dos Santos, et al.
Published: (2021-03-01)
Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis
by: Lorenzo Sanesi, et al.
Published: (2023-01-01)
by: Lorenzo Sanesi, et al.
Published: (2023-01-01)
Lack of Association Between FNDC5 Gene Polymorphisms, Serum Irisin Levels and Allergic Rhinitis
by: Hüseyin Günizi, et al.
Published: (2023-10-01)
by: Hüseyin Günizi, et al.
Published: (2023-10-01)
Irisin regulates pancreatic lipases through PPARγ-PGCα-FNDC5 pathway
by: Horwitz Avital, et al.
Published: (2023-01-01)
by: Horwitz Avital, et al.
Published: (2023-01-01)
Deletion of FNDC5/irisin modifies murine osteocyte function in a sex-specific manner
by: Anika Shimonty, et al.
Published: (2024-04-01)
by: Anika Shimonty, et al.
Published: (2024-04-01)
Are Heart Muscle Irisin Levels and FNDC5 Gene Expression Regulated by Endurance and Resistance Exercises?
by: Mohammad Hosseinzadeh, et al.
Published: (2018-04-01)
by: Mohammad Hosseinzadeh, et al.
Published: (2018-04-01)
FNDC5/irisin mediates the protective effects of Innovative theta-shaking exercise on mouse memory
by: Runhong Yao, et al.
Published: (2024-04-01)
by: Runhong Yao, et al.
Published: (2024-04-01)
Cystine-cored diphenylalanine appended peptide-based self-assembled fluorescent nanostructures direct redox-responsive drug delivery
by: Suman Nayak, et al.
Published: (2024-04-01)
by: Suman Nayak, et al.
Published: (2024-04-01)
Evolutionary Insights into Irisin/FNDC5: Roles in Aging and Disease from <i>Drosophila</i> to Mammals
by: Kiwon Lee, et al.
Published: (2025-02-01)
by: Kiwon Lee, et al.
Published: (2025-02-01)
Cardiotoxic effects of chemotherapeutical treatment in oncological patient
by: D. P. Kotova, et al.
Published: (2019-04-01)
by: D. P. Kotova, et al.
Published: (2019-04-01)
Exercise-Induced FNDC5/Irisin Ameliorates Cognitive Impairment in Aged Mice, Associated with Antioxidant and Neurotrophic Responses
by: Jae Min Lee, et al.
Published: (2025-10-01)
by: Jae Min Lee, et al.
Published: (2025-10-01)
Associations of Circulating Irisin with FNDC5 Expression in Fat and Muscle in Type 1 and Type 2 Diabetic Mice
by: Songling Jiang, et al.
Published: (2021-02-01)
by: Songling Jiang, et al.
Published: (2021-02-01)
MODERN VIEW ON CARDIOTOXICITY OF CHEMOTHERAPEUTICS IN ONCOLOGY INCLUDING ANTHRACYCLINES
by: G. E. Gendlin, et al.
Published: (2017-03-01)
by: G. E. Gendlin, et al.
Published: (2017-03-01)
FNDC5/irisin ameliorates bone loss of type 1 diabetes by suppressing endoplasmic reticulum stress‑mediated ferroptosis
by: Qianqian Dong, et al.
Published: (2024-03-01)
by: Qianqian Dong, et al.
Published: (2024-03-01)
FNDC5/irisin-enriched sEVs conjugated with bone-targeting aptamer alleviate osteoporosis: a potential alternative to exercise
by: Min-Zhi Mao, et al.
Published: (2025-07-01)
by: Min-Zhi Mao, et al.
Published: (2025-07-01)
Dietary Intervention, When Not Associated With Exercise, Upregulates Irisin/FNDC5 While Reducing Visceral Adiposity Markers in Obese Rats
by: Vanessa de Oliveira Furino, et al.
Published: (2021-08-01)
by: Vanessa de Oliveira Furino, et al.
Published: (2021-08-01)
Cardiotoxicity of Chemotherapeutic Drugs (Literature Review and Clinical Case Description)
by: Avagimyan Ashot A., et al.
Published: (2019-12-01)
by: Avagimyan Ashot A., et al.
Published: (2019-12-01)
Irisin/FNDC5 Regulates Endothelial Function to Improve Post‐Stroke‐Induced Cognitive Dysfunction by Stimulating AMPK‐eNOS Signaling
by: Hui‐Hui Guo, et al.
Published: (2025-09-01)
by: Hui‐Hui Guo, et al.
Published: (2025-09-01)
Exercise Training Enhances Myocardial Mitophagy and Improves Cardiac Function via Irisin/FNDC5-PINK1/Parkin Pathway in MI Mice
by: Hangzhuo Li, et al.
Published: (2021-06-01)
by: Hangzhuo Li, et al.
Published: (2021-06-01)
Comparative Genomic Characterization of Buffalo Fibronectin Type III Domain Proteins: Exploring the Novel Role of FNDC5/Irisin as a Ligand of Gonadal Receptors
by: Siwen Wu, et al.
Published: (2021-11-01)
by: Siwen Wu, et al.
Published: (2021-11-01)
Preclinical Evaluation of Dimethyl Itaconate Against Hepatocellular Carcinoma via Activation of the e/iNOS-Mediated NF-κB–Dependent Apoptotic Pathway
by: Anurag Kumar Gautam, et al.
Published: (2022-01-01)
by: Anurag Kumar Gautam, et al.
Published: (2022-01-01)
Molecular perspectives on systemic priming and concomitant immunity in colorectal carcinoma
by: Suman Kumar Ray, et al.
Published: (2024-03-01)
by: Suman Kumar Ray, et al.
Published: (2024-03-01)
The Acute Effects of Swimming Exercise on PGC-1α-FNDC5/Irisin-UCP1 Expression in Male C57BL/6J Mice
by: Eunhee Cho, et al.
Published: (2021-02-01)
by: Eunhee Cho, et al.
Published: (2021-02-01)
Irisin Ameliorate Acute Pancreatitis and Acinar Cell Viability through Modulation of the Unfolded Protein Response (UPR) and PPARγ-PGC1α-FNDC5 Pathways
by: Avital Horwitz, et al.
Published: (2024-05-01)
by: Avital Horwitz, et al.
Published: (2024-05-01)
Chronic voluntary wheel running exercise ameliorates metabolic dysfunction via PGC-1α expression independently of FNDC5/irisin pathway in high fat diet-induced obese mice
by: Chaeeun Cho, et al.
Published: (2023-04-01)
by: Chaeeun Cho, et al.
Published: (2023-04-01)
Chemotherapeutic Interventions Against Tuberculosis
by: Neeraj Shakya, et al.
Published: (2012-06-01)
by: Neeraj Shakya, et al.
Published: (2012-06-01)
Evaluation of Left Atrial Electromechanical Delay and Left Atrial Phasic Functions in Patients Undergoing Treatment with Cardiotoxic Chemotherapeutic Agents
by: Ömer Kertmen, et al.
Published: (2024-09-01)
by: Ömer Kertmen, et al.
Published: (2024-09-01)
Gene Location, Expression, and Function of FNDC5 in Meishan Pigs
by: Chunbo Cai, et al.
Published: (2017-08-01)
by: Chunbo Cai, et al.
Published: (2017-08-01)
Irisin suppressed the progression of TBI via modulating AMPK/MerTK/autophagy and SYK/ROS/inflammatory signaling
by: Kuo Zhang, et al.
Published: (2025-05-01)
by: Kuo Zhang, et al.
Published: (2025-05-01)
WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis
by: Panpan Tai, et al.
Published: (2023-11-01)
by: Panpan Tai, et al.
Published: (2023-11-01)
Role of chemotherapeutic drugs in immunomodulation of cancer
by: Oishi Mukherjee, et al.
Published: (2023-01-01)
by: Oishi Mukherjee, et al.
Published: (2023-01-01)
The efficacy of VAC therapy on chemotherapeutic extravasation ulcers: An experimental study
by: Vinay Kumar Tiwari
Published: (2014-09-01)
by: Vinay Kumar Tiwari
Published: (2014-09-01)
Investigation of rs1746661 Polymorphism in FNDC5 Gene in Obese Patients
by: Elham Hadi, et al.
Published: (2024-12-01)
by: Elham Hadi, et al.
Published: (2024-12-01)
Similar Items
-
Corrigendum to “FNDC5/irisin mitigates the cardiotoxic impacts of cancer chemotherapeutics by modulating ROS-dependent and -independent mechanisms” [Redox Biol. 80 (2025) 103527]
by: Manish Kumar, et al.
Published: (2025-09-01) -
RGS6 drives cardiomyocyte death following nucleolar stress by suppressing Nucleolin/miRNA-21
by: Abhishek Singh Sengar, et al.
Published: (2024-02-01) -
FNDC5/Irisin: Physiology and Pathophysiology
by: Rashid Waseem, et al.
Published: (2022-02-01) -
The Role of FNDC5/Irisin in Cardiovascular Disease
by: Maciej Grzeszczuk, et al.
Published: (2024-02-01) -
RGS11-CaMKII complex mediated redox control attenuates chemotherapy-induced cardiac fibrosis
by: Kiran Das, et al.
Published: (2022-11-01)
